|
G
|
Akt1
|
AKT serine/threonine kinase 1
|
decreases expression
|
ISO
|
syringic acid results in decreased expression of AKT1 mRNA; syringic acid results in decreased expression of AKT1 protein
|
CTD |
PMID:33548266 PMID:33759321 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
G
|
Alpl
|
alkaline phosphatase, biomineralization associated
|
multiple interactions
|
EXP
|
syringic acid inhibits the reaction [Valproic Acid results in increased activity of ALPL protein]
|
CTD |
PMID:35543257 |
|
NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:155,234,775...155,254,167
|
|
G
|
Apaf1
|
apoptotic peptidase activating factor 1
|
multiple interactions
|
EXP
|
syringic acid inhibits the reaction [Mercuric Chloride results in increased expression of APAF1 mRNA]
|
CTD |
PMID:39096083 |
|
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772
|
|
G
|
Atf4
|
activating transcription factor 4
|
multiple interactions
|
EXP
|
syringic acid inhibits the reaction [Mercuric Chloride results in increased expression of ATF4 mRNA]
|
CTD |
PMID:39096083 |
|
NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739
|
|
G
|
Atf6
|
activating transcription factor 6
|
multiple interactions
|
EXP
|
syringic acid inhibits the reaction [Mercuric Chloride results in increased expression of ATF6 mRNA]
|
CTD |
PMID:39096083 |
|
NCBI chr13:85,460,312...85,639,959
Ensembl chr13:85,462,840...85,640,033
|
|
G
|
Atg3
|
autophagy related 3
|
increases expression
|
ISO
|
syringic acid results in increased expression of ATG3 protein
|
CTD |
PMID:33548266 |
|
NCBI chr11:69,130,948...69,159,280
Ensembl chr11:69,121,952...69,159,280
|
|
G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
increases expression multiple interactions
|
ISO EXP
|
syringic acid results in increased expression of BAX mRNA syringic acid inhibits the reaction [Mercuric Chloride results in increased expression of BAX mRNA]
|
CTD |
PMID:33759321 PMID:39096083 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
G
|
Bcl2
|
BCL2, apoptosis regulator
|
decreases expression multiple interactions
|
ISO EXP
|
syringic acid results in decreased expression of BCL2 mRNA syringic acid inhibits the reaction [Mercuric Chloride results in decreased expression of BCL2 mRNA]
|
CTD |
PMID:33759321 PMID:39096083 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
G
|
Becn1
|
beclin 1
|
increases expression multiple interactions
|
ISO EXP
|
syringic acid results in increased expression of BECN1 protein syringic acid inhibits the reaction [Mercuric Chloride results in increased expression of BECN1 protein]
|
CTD |
PMID:33548266 PMID:39096083 |
|
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002
|
|
G
|
Casp3
|
caspase 3
|
increases expression increases secretion multiple interactions
|
ISO EXP
|
syringic acid results in increased expression of CASP3 mRNA syringic acid analog results in increased secretion of CASP3 protein HSPA1A protein inhibits the reaction [syringic acid analog results in increased secretion of CASP3 protein] syringic acid inhibits the reaction [Mercuric Chloride results in increased expression of CASP3 mRNA]; syringic acid inhibits the reaction [Mercuric Chloride results in increased expression of CASP3 protein]
|
CTD |
PMID:33759321 PMID:34523043 PMID:39096083 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
G
|
Casp8
|
caspase 8
|
increases expression
|
ISO
|
syringic acid results in increased expression of CASP8 mRNA
|
CTD |
PMID:33759321 |
|
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
|
|
G
|
Casp9
|
caspase 9
|
increases expression multiple interactions increases secretion
|
ISO
|
syringic acid results in increased expression of CASP9 mRNA aloxistatin inhibits the reaction [syringic acid analog results in increased secretion of CASP9 protein]; pepstatin inhibits the reaction [syringic acid analog results in increased secretion of CASP9 protein]
|
CTD |
PMID:33759321 PMID:34523043 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
G
|
Cat
|
catalase
|
decreases activity multiple interactions increases activity
|
ISO EXP
|
syringic acid results in decreased activity of CAT protein syringic acid inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]; syringic acid inhibits the reaction [Propylthiouracil results in decreased activity of CAT protein]; syringic acid inhibits the reaction [Valproic Acid results in decreased activity of CAT protein]; syringic acid inhibits the reaction [Valproic Acid results in decreased expression of CAT protein] syringic acid results in increased activity of CAT protein
|
CTD |
PMID:33548266 PMID:34047416 PMID:35543257 PMID:37357844 PMID:39096083 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
G
|
Ccnd1
|
cyclin D1
|
decreases expression
|
ISO
|
syringic acid results in decreased expression of CCND1 mRNA
|
CTD |
PMID:33759321 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
G
|
Cdk2
|
cyclin dependent kinase 2
|
decreases expression
|
ISO
|
syringic acid results in decreased expression of CDK2 mRNA
|
CTD |
PMID:33759321 |
|
NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878
|
|
G
|
Cdk4
|
cyclin-dependent kinase 4
|
decreases expression
|
ISO
|
syringic acid results in decreased expression of CDK4 mRNA
|
CTD |
PMID:33759321 |
|
NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163
|
|
G
|
Ddit3
|
DNA-damage inducible transcript 3
|
multiple interactions
|
EXP
|
syringic acid inhibits the reaction [Mercuric Chloride results in increased expression of DDIT3 mRNA]
|
CTD |
PMID:39096083 |
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
|
|
G
|
Dhfr
|
dihydrofolate reductase
|
decreases activity
|
ISO
|
syringic acid results in decreased activity of DHFR protein
|
CTD |
PMID:25418905 |
|
NCBI chr 2:25,320,895...25,346,004
|
|
G
|
Eif2ak3
|
eukaryotic translation initiation factor 2 alpha kinase 3
|
multiple interactions
|
EXP
|
syringic acid inhibits the reaction [Mercuric Chloride results in increased expression of EIF2AK3 mRNA]
|
CTD |
PMID:39096083 |
|
NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:104,363,833...104,425,268
|
|
G
|
Eif2s1
|
eukaryotic translation initiation factor 2 subunit alpha
|
multiple interactions
|
EXP
|
syringic acid inhibits the reaction [Mercuric Chloride results in increased expression of EIF2S1 mRNA]
|
CTD |
PMID:39096083 |
|
NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:103,405,788...103,431,649
|
|
G
|
Fadd
|
Fas associated via death domain
|
increases secretion multiple interactions
|
ISO
|
syringic acid analog results in increased secretion of FADD protein HSPA1A protein inhibits the reaction [syringic acid analog results in increased secretion of FADD protein]
|
CTD |
PMID:34523043 |
|
NCBI chr 1:209,169,245...209,175,423
Ensembl chr 1:209,169,318...209,174,976
|
|
G
|
G3bp1
|
G3BP stress granule assembly factor 1
|
multiple interactions
|
ISO
|
syringic acid analog results in increased expression of and affects the localization of G3BP1 protein
|
CTD |
PMID:34523043 |
|
NCBI chr10:40,087,533...40,120,931
Ensembl chr10:40,087,533...40,120,931
|
|
G
|
Gapdh
|
glyceraldehyde-3-phosphate dehydrogenase
|
multiple interactions increases secretion
|
ISO
|
aloxistatin inhibits the reaction [syringic acid analog results in increased secretion of GAPDH protein]; HSPA1A protein inhibits the reaction [syringic acid analog results in increased secretion of GAPDH protein]; pepstatin inhibits the reaction [syringic acid analog results in increased secretion of GAPDH protein]
|
CTD |
PMID:34523043 |
|
NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:159,648,592...159,653,377
|
|
G
|
Got1
|
glutamic-oxaloacetic transaminase 1
|
multiple interactions
|
EXP
|
syringic acid inhibits the reaction [Valproic Acid results in increased activity of GOT1 protein]
|
CTD |
PMID:35543257 |
|
NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:252,284,434...252,329,871
|
|
G
|
Gpt
|
glutamic--pyruvic transaminase
|
multiple interactions
|
EXP
|
syringic acid inhibits the reaction [Propylthiouracil results in increased expression of GPT protein]; syringic acid inhibits the reaction [Valproic Acid results in increased activity of GPT protein]
|
CTD |
PMID:34047416 PMID:35543257 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
|
|
G
|
Gsk3b
|
glycogen synthase kinase 3 beta
|
multiple interactions
|
ISO
|
syringic acid inhibits the reaction [Excitatory Amino Acid Agonists results in decreased expression of and results in decreased phosphorylation of GSK3B protein]
|
CTD |
PMID:31586550 |
|
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249
|
|
G
|
Gsr
|
glutathione-disulfide reductase
|
decreases activity
|
ISO
|
syringic acid results in decreased activity of GSR protein
|
CTD |
PMID:33548266 |
|
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
|
|
G
|
Hspa1a
|
heat shock protein family A (Hsp70) member 1A
|
multiple interactions
|
ISO
|
HSPA1A protein inhibits the reaction [syringic acid analog results in increased secretion of CASP3 protein]; HSPA1A protein inhibits the reaction [syringic acid analog results in increased secretion of FADD protein]; HSPA1A protein inhibits the reaction [syringic acid analog results in increased secretion of GAPDH protein]
|
CTD |
PMID:34523043 |
|
NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979
|
|
G
|
Il10
|
interleukin 10
|
decreases secretion
|
ISO
|
syringic acid results in decreased secretion of IL10 protein
|
CTD |
PMID:33759321 |
|
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
G
|
Il1b
|
interleukin 1 beta
|
multiple interactions
|
EXP
|
syringic acid inhibits the reaction [Mercuric Chloride results in increased expression of IL1B mRNA]; syringic acid inhibits the reaction [Mercuric Chloride results in increased expression of IL1B protein]
|
CTD |
PMID:39096083 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
G
|
Il2
|
interleukin 2
|
decreases secretion
|
ISO
|
syringic acid results in decreased secretion of IL2 protein
|
CTD |
PMID:33759321 |
|
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672
|
|
G
|
Il6
|
interleukin 6
|
decreases secretion multiple interactions
|
ISO EXP
|
syringic acid results in decreased secretion of IL6 protein syringic acid inhibits the reaction [Propylthiouracil results in increased expression of IL6 protein]; syringic acid inhibits the reaction [Valproic Acid results in increased expression of IL6 mRNA]; syringic acid inhibits the reaction [Valproic Acid results in increased expression of IL6 protein]
|
CTD |
PMID:33759321 PMID:34047416 PMID:35543257 PMID:37357844 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
G
|
Mapk1
|
mitogen activated protein kinase 1
|
decreases expression
|
ISO
|
syringic acid results in decreased expression of MAPK1 protein
|
CTD |
PMID:33548266 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
G
|
Mapk14
|
mitogen activated protein kinase 14
|
decreases expression
|
ISO
|
syringic acid results in decreased expression of MAPK14 mRNA
|
CTD |
PMID:33759321 |
|
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294
|
|
G
|
Mapk3
|
mitogen activated protein kinase 3
|
decreases expression
|
ISO
|
syringic acid results in decreased expression of MAPK3 protein
|
CTD |
PMID:33548266 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
G
|
Mapk8
|
mitogen-activated protein kinase 8
|
decreases expression
|
ISO
|
syringic acid results in decreased expression of MAPK8 mRNA
|
CTD |
PMID:33759321 |
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
|
|
G
|
Mapk9
|
mitogen-activated protein kinase 9
|
multiple interactions
|
EXP
|
syringic acid inhibits the reaction [Valproic Acid results in increased expression of MAPK9 mRNA]
|
CTD |
PMID:35543257 |
|
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,670,756...34,712,228
|
|
G
|
Mpo
|
myeloperoxidase
|
decreases activity
|
ISO
|
syringic acid results in decreased activity of MPO protein
|
CTD |
PMID:24060682 |
|
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056
|
|
G
|
Nfkb1
|
nuclear factor kappa B subunit 1
|
multiple interactions
|
EXP
|
syringic acid inhibits the reaction [Mercuric Chloride results in increased expression of NFKB1 mRNA]
|
CTD |
PMID:39096083 |
|
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088
|
|
G
|
Nfkbib
|
NFKB inhibitor beta
|
multiple interactions
|
EXP
|
syringic acid inhibits the reaction [Valproic Acid results in decreased expression of NFKBIB mRNA]
|
CTD |
PMID:35543257 |
|
NCBI chr 1:93,173,817...93,181,387
Ensembl chr 1:93,173,820...93,326,366
|
|
G
|
Pin1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
decreases expression
|
ISO
|
syringic acid results in decreased expression of PIN1 mRNA
|
CTD |
PMID:33759321 |
|
NCBI chr 8:27,465,538...27,477,016
|
|
G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
multiple interactions
|
EXP
|
syringic acid inhibits the reaction [Valproic Acid results in increased expression of PTGS2 protein]
|
CTD |
PMID:35543257 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
decreases expression
|
ISO
|
syringic acid results in decreased expression of RELA mRNA
|
CTD |
PMID:33759321 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
G
|
Sod1
|
superoxide dismutase 1
|
multiple interactions
|
EXP
|
syringic acid inhibits the reaction [Valproic Acid results in decreased activity of SOD1 protein]
|
CTD |
PMID:35543257 |
|
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
|
|
G
|
Sqstm1
|
sequestosome 1
|
increases expression
|
ISO
|
syringic acid analog results in increased expression of SQSTM1 protein
|
CTD |
PMID:34523043 |
|
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:35,026,598...35,037,750
|
|
G
|
Stat3
|
signal transducer and activator of transcription 3
|
decreases expression
|
ISO
|
syringic acid results in decreased expression of STAT3 mRNA
|
CTD |
PMID:33759321 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
|
|
G
|
Tnf
|
tumor necrosis factor
|
decreases secretion multiple interactions
|
ISO EXP
|
syringic acid results in decreased secretion of TNF protein syringic acid inhibits the reaction [Mercuric Chloride results in increased expression of TNF mRNA]; syringic acid inhibits the reaction [Propylthiouracil results in increased expression of TNF protein]; syringic acid inhibits the reaction [Valproic Acid results in increased expression of TNF protein]
|
CTD |
PMID:33759321 PMID:34047416 PMID:35543257 PMID:37357844 PMID:39096083 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
G
|
Tp53
|
tumor protein p53
|
increases expression
|
ISO
|
syringic acid results in increased expression of TP53 protein
|
CTD |
PMID:33548266 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
G
|
Tshb
|
thyroid stimulating hormone subunit beta
|
multiple interactions decreases expression
|
EXP
|
syringic acid inhibits the reaction [Propylthiouracil results in increased expression of TSHB protein] syringic acid results in decreased expression of TSHB protein
|
CTD |
PMID:34047416 |
|
NCBI chr 2:192,913,171...192,918,054
Ensembl chr 2:192,913,171...192,942,984
|
|